Few companies stand better poised than Beam Therapeutics to reap the first fruits of the FDA’s promised flexibility toward cell and gene therapies. The biotech is pioneering treatments based on base ...

Beam Therapeutics Inc. pivots from platform story to execution-driven thesis, with regulatory clarity accelerating BEAM-302 and Risto-cel in 2026. BEAM-302's "in vivo" gene editing for AATD achieved a ...

OAKLAND — They came from as far away as Connecticut and Georgia, and from as close as Laney College across the street. They were Super Bowl champions and members of Congress. They were coaches, ...

PORTLAND, Ore. — One way or another, changes are coming for Multnomah County's drug deflection program — though the details may depend on how much the county's district attorney and commissioners can ...

World-famous Kentucky whiskey brand Jim Beam is reportedly closing its production facility in Clermont starting Jan. 1 through the end of 2026. The company is shifting production to its larger Booker ...

Bourbon maker Jim Beam is halting production at one of its distilleries in Kentucky for at least a year as the whiskey industry navigates tariffs from the Trump administration and slumping demand for ...

This is read by an automated voice. Please report any issues or inconsistencies here. Bourbon maker Jim Beam is halting production at its Clermont distillery for at least a year in 2026 due to Trump ...

Bourbon maker Jim Beam is halting production at one of its distilleries in Kentucky for at least a year as the whiskey industry navigates tariffs from the Trump administration and slumping demand for ...

Popular Kentucky bourbon maker Jim Beam plans to pause production at its main distillery on January 1, according to the James B. Beam Distilling Co. The decision comes as Kentucky faces an increasing ...

Beam Therapeutics (BEAM) just released new BEACON trial data on its sickle cell therapy risto cel, showing durable hemoglobin F gains, lower hemoglobin S, and anemia resolution that help explain the ...

In response to low engagement in Multnomah County’s drug deflection program, District Attorney Nathan Vasquez has announced steep changes. Starting Jan. 5, people that fail to complete the county’s ...